Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00697385 · ClinicalTrials.gov registry record · NA
The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders
A NA study of Hemophilia and vonWillebrand Disease, sponsored by Mary M. Gooley Hemophilia Center.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT00697385 is a NA study of Hemophilia and vonWillebrand Disease that has completed, run by Mary M. Gooley Hemophilia Center. The registered enrollment target is 13 participants, below the 409-participant average among 9 other Hemophilia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00697385, a NA study of Hemophilia and vonWillebrand Disease, has completed, sponsored by Mary M. Gooley Hemophilia Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The high percentage of failure using available non-surgical options to treat menorrhagia in women with bleeding disorders shows a continuing need for innovative treatments. This has led to development of this protocol in order to make available tranexamic acid as a potentially effective menorrhagia therapy option in women with an underlying bleeding disorder. We anticipate that Tranexamic Acid may be a beneficial choice for controlling menorrhagia in bleeding disorder patients.
Conditions Studied
Interventions
- DRUG Cyclokapron
Study Locations (1)
New York
- Mary M. Gooley Hemophilia Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2003-04 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00697385
The ClinicalTrials.gov registry entry for NCT00697385 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 409-participant average among 9 other Hemophilia trials with a reported enrollment target (97% lower). The listed sponsor is Mary M. Gooley Hemophilia Center, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hemophilia appearing as the primary indexed condition, and to 1 intervention - of which Cyclokapron is the first listed.
NCT00697385 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00697385 about?
NCT00697385 is a clinical study titled "The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders". The high percentage of failure using available non-surgical options to treat menorrhagia in women with bleeding disorders shows a continuing need for innovative treatments. This has led to development of this protocol in order to make available tranexamic acid as a potentially effective menorrhagia ...
What is the current status of trial NCT00697385?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2003-04. Estimated completion is 2008-06.
What conditions does trial NCT00697385 study?
This clinical trial studies the following conditions: Hemophilia, vonWillebrand Disease, Platelet Coagulation Disorders.
What interventions are being tested in trial NCT00697385?
The interventions under investigation include: Cyclokapron (DRUG).
Who is sponsoring clinical trial NCT00697385?
This trial is sponsored by Mary M. Gooley Hemophilia Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00697385 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemophilia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Trial of Factor XIII (FXIII) Concentrate
COMPLETED · NA
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study
RECRUITING · Early Phase 1
-
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
RECRUITING · Phase 3
-
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
ACTIVE NOT RECRUITING · Phase 3
-
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.